Cargando…
Early administration of L‐arginine in mdx neonatal mice delays the onset of muscular dystrophy in tibialis anterior (TA) muscle
Duchenne muscular dystrophy (DMD) is a genetic disorder that results in the absence of dystrophin, a cytoskeletal protein. Individuals with this disease experience progressive muscle destruction, which leads to muscle weakness. Studies have been conducted to find solutions for the relief of individu...
Autores principales: | Dudley, Roy W. R., Comtois, Alain S., St‐Pierre, David H., Danialou, Gawiyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332474/ https://www.ncbi.nlm.nih.gov/pubmed/34377959 http://dx.doi.org/10.1096/fba.2020-00104 |
Ejemplares similares
-
Arginine Metabolism by Macrophages Promotes Cardiac and Muscle Fibrosis in mdx Muscular Dystrophy
por: Wehling-Henricks, Michelle, et al.
Publicado: (2010) -
Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Guerron, Alfredo D., et al.
Publicado: (2010) -
Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2
por: Mojumdar, Kamalika, et al.
Publicado: (2014) -
Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy
por: Aranmolate, Azeez, et al.
Publicado: (2017) -
Profiling of Age-Related Changes in the Tibialis Anterior Muscle Proteome of the mdx Mouse Model of Dystrophinopathy
por: Carberry, Steven, et al.
Publicado: (2012)